NASDAQ Companies - Bay Street News

NASDAQ Companies - June 22, 2020

BeiGene and SpringWorks Announce Presentation of Preclinical Data Combining RAF Dimer Inhibitor Lifirafenib with MEK Inhibitor Mirdametinib and Provide Update on Ongoing Phase 1b/2 Clinical Trial

Preclinical data presented at the American Association for Cancer Research 2020 Virtual Annual Meeting IIOngoing Phase 1b/2 clinical trial on […]

NASDAQ Companies - June 22, 2020

Turning Point Therapeutics’ Lead Drug Candidate Repotrectinib Increases Effectiveness of KRAS-G12C and MEK Inhibitors in Preclincal KRAS Cancer Models

SAN DIEGO, June 22, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation […]

NASDAQ Companies - June 22, 2020

LPL Financial and JFC Financial Services Welcome Fogarty Wealth Management

CHARLOTTE, N.C., June 22, 2020 (GLOBE NEWSWIRE) — LPL Financial LLC, a leading retail investment advisory firm and independent broker-dealer, […]

NASDAQ Companies - June 22, 2020

Flushing Bank Receives Grant Money from Federal Home Loan Bank of New York’s (FHLBNY) Small Business Recovery Grant Program to Assist Local Small Businesses and Non-Profit Organizations

UNIONDALE, N.Y., June 22, 2020 (GLOBE NEWSWIRE) — Flushing Financial Corporation (the “Company”) (Nasdaq: FFIC), the parent holding company for […]

NASDAQ Companies - June 22, 2020

TG Therapeutics Announces Preclinical Data Presentation at the 2020 American Association for Cancer Research Annual Meeting

NEW YORK, June 22, 2020 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced preclinical data presentation for TG-1701, […]

NASDAQ Companies - June 22, 2020

Jounce Therapeutics Presents First Preclinical Data on Anti-CCR8 Antibody JTX-1811 and Vopratelimab Translational Data at The American Association for Cancer Research Virtual Annual Meeting

– Preclinical data supports the development of JTX-1811, targeting CCR8, as a novel immunotherapy for the selective depletion of immunosuppressive […]

NASDAQ Companies - June 22, 2020

MacroGenics Announces Presentation of Preclinical Data at the 2020 AACR Annual Meeting

Rockville, MD, June 22, 2020 (GLOBE NEWSWIRE) —MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing […]

NASDAQ Companies - June 22, 2020

Dynavax to Present at the H.C. Wainwright Virtual Fireside Chat Series

EMERYVILLE, Calif., June 22, 2020 (GLOBE NEWSWIRE) — Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and […]

NASDAQ Companies - June 22, 2020

Beyond Air Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors

Data demonstrate the ablation of solid tumors with nitric oxideAll tumor-bearing mice treated with nitric oxide rejected a second tumor […]

NASDAQ Companies - June 22, 2020

ORIC Pharmaceuticals Presents Preclinical Data on Glucocorticoid Receptor Antagonist and CD73 Inhibitor Programs at the 2020 American Association for Cancer Research Virtual Annual Meeting II

SOUTH SAN FRANCISCO, Calif., June 22, 2020 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company […]